Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
DRUG
DRUG Financials
-
Add to Watchlist
Trade DRUG
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
DRUG Income Statement - Revenue & EPS - Intellectia AI™
Summary
Key Indicators
Income Statement
Balance Sheet
Cash Flow
YoY
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Selling General & Administrative Expenses
6.90M
+326.25%
5.66M
+617.28%
3.29M
+368.4%
3.34M
+279.71%
1.62M
-4.59%
788.70K
-50.15%
701.92K
-51.38%
879.22K
-57.08%
1.70M
-26.01%
1.58M
-47.42%
1.44M
-45.78%
2.05M
-54.24%
2.29M
-52.48%
3.01M
+1.43%
2.66M
-27%
4.48M
+187.96%
4.82M
+681.56%
2.97M
--
3.65M
--
1.55M
--
617.22K
--
Research & Development Expense
5.66M
+441.5%
4.78M
+1049.9%
2.69M
+625.26%
2.56M
+498.2%
1.04M
-14.7%
416.06K
-61.88%
371.16K
-64.67%
428.47K
-69.36%
1.23M
-16.04%
1.09M
-57.06%
1.05M
-48.78%
1.40M
-62.65%
1.46M
-62.04%
2.54M
+15.08%
2.05M
-24.25%
3.74M
+295.54%
3.85M
+1311.24%
2.21M
--
2.71M
--
946.35K
--
272.47K
--
Other Operating Expense - Net
--
--
--
--
--
-100%
--
-100%
--
--
--
--
-937.90K
--
-323.29K
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
-100%
0.00
-100%
0.00
--
0.00
--
1.46K
--
17.21K
--
Operating Profit
-6.90M
+326.25%
-5.66M
+617.28%
-3.29M
-1493.23%
-3.34M
+500.52%
-1.62M
-4.59%
-788.70K
-50.15%
235.98K
-116.35%
-555.94K
-72.86%
-1.70M
-26.01%
-1.58M
-47.42%
-1.44M
-45.78%
-2.05M
-54.24%
-2.29M
-52.48%
-3.01M
+1.43%
-2.66M
-27%
-4.48M
+187.69%
-4.82M
+660.36%
-2.97M
--
-3.65M
--
-1.56M
--
-634.43K
--
Financing Income- Net
-667.81K
-140.04%
1.83M
+11887.37%
-2.21M
+36298.8%
388.12K
-2231.92%
1.67M
+14082.01%
15.26K
-71.81%
-6.08K
-58.59%
-18.20K
+890.48%
11.76K
-127.23%
54.15K
+8.3%
-14.68K
-443.6%
-1.84K
-81.99%
-43.19K
+26.7%
50.00K
-49.82%
4.27K
-96.25%
-10.21K
-62.15%
-34.09K
+4.47%
99.63K
--
114.06K
--
-26.96K
--
-32.63K
--
Interest Expense
-811.69K
-38047.03%
-522.24K
+15260.06%
-467.71K
+3302.54%
-495.80K
-23420.84%
2.14K
-28%
-3.40K
-189.8%
-13.75K
-400.39%
2.13K
-60.14%
2.97K
-50.93%
3.79K
+74.23%
4.58K
--
5.33K
--
6.05K
--
2.17K
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Non-Interest Financial Income
-1.48M
-188.6%
1.31M
+10920.65%
-2.68M
+13421.44%
-107.69K
+569.72%
1.67M
+11236.25%
11.86K
-79.52%
-19.83K
+96.18%
-16.08K
-560.06%
14.73K
-139.67%
57.93K
+11.05%
-10.11K
-336.51%
3.50K
-134.24%
-37.13K
+8.94%
52.17K
-47.64%
4.27K
-96.25%
-10.21K
-62.15%
-34.09K
+4.47%
99.63K
--
114.06K
--
-26.96K
--
-32.63K
--
Other Non-Operating Income
--
--
-257.87K
--
257.87K
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Income before Taxes
-7.57M
-15349.58%
-4.09M
+428.24%
-5.24M
-2380.51%
-2.95M
+413.88%
49.61K
-102.95%
-773.44K
-49.38%
229.90K
-115.77%
-574.14K
-72%
-1.68M
-27.88%
-1.53M
-48.4%
-1.46M
-45.14%
-2.05M
-54.31%
-2.33M
-51.93%
-2.96M
+3.28%
-2.66M
-24.77%
-4.49M
+183.43%
-4.86M
+628.28%
-2.87M
--
-3.53M
--
-1.58M
--
-667.06K
--
Net Income after Tax
-7.57M
-15349.58%
-4.09M
+428.24%
-5.24M
-2380.51%
-2.95M
+413.88%
49.61K
-102.95%
-773.44K
-49.38%
229.90K
-115.77%
-574.14K
-72%
-1.68M
-27.88%
-1.53M
-48.4%
-1.46M
-45.14%
-2.05M
-54.31%
-2.33M
-51.93%
-2.96M
+3.28%
-2.66M
-24.77%
-4.49M
+183.43%
-4.86M
+628.28%
-2.87M
--
-3.53M
--
-1.58M
--
-667.06K
--
Income Available to Common Shares
-7.57M
-15349.58%
-4.09M
+428.24%
-5.24M
-2380.51%
-2.95M
+413.88%
49.61K
-102.95%
-773.44K
-49.38%
229.90K
-115.77%
-574.14K
-72%
-1.68M
-27.88%
-1.53M
-48.4%
-1.46M
-45.14%
-2.05M
-54.31%
-2.33M
-51.93%
-2.96M
+3.28%
-2.66M
-24.77%
-4.49M
+183.43%
-4.86M
+628.28%
-2.87M
+657.62%
-3.53M
+6465.09%
-1.58M
+25677.87%
-667.06K
--
EPS - Basic
-0.97
-9800%
-0.59
+247.06%
-0.74
-1580%
-0.42
+223.08%
0.01
-102.27%
-0.17
-58.54%
0.05
-102.59%
-0.13
-75.93%
-0.44
-32.31%
-0.41
-61.68%
-1.93
+72.32%
-0.54
-71.43%
-0.65
-68.29%
-1.07
-11.57%
-1.12
-28.21%
-1.89
+65.79%
-2.05
+253.45%
-1.21
+303.33%
-1.56
+3800%
-1.14
--
-0.58
--
EPS - Diluted
-0.97
-9800%
-0.59
+247.06%
-0.74
-1580%
-0.42
+223.08%
0.01
-102.27%
-0.17
-58.54%
0.05
-102.59%
-0.13
-75.93%
-0.44
-32.31%
-0.41
-61.68%
-1.93
+72.32%
-0.54
-71.43%
-0.65
-68.29%
-1.07
-11.57%
-1.12
-28.21%
-1.89
+65.79%
-2.05
+253.45%
-1.21
+303.33%
-1.56
+3800%
-1.14
--
-0.58
--
EBIT
-6.90M
+326.25%
-5.66M
+617.28%
-3.29M
-1493.23%
-3.34M
+500.52%
-1.62M
-4.59%
-788.70K
-50.15%
235.98K
-116.35%
-555.94K
-72.86%
-1.70M
-26.01%
-1.58M
-47.42%
-1.44M
-45.78%
-2.05M
-54.24%
-2.29M
-52.48%
-3.01M
+1.43%
-2.66M
-27%
-4.48M
+187.69%
-4.82M
+660.36%
-2.97M
--
-3.65M
--
-1.56M
--
-634.43K
--
EBITDA
-6.88M
+330.76%
-5.64M
+632.8%
-3.27M
-1387.68%
-3.32M
+516.56%
-1.60M
-4.84%
-769.68K
-50.79%
254.10K
-117.82%
-537.82K
-73.51%
-1.68M
-26.22%
-1.56M
-47.92%
-1.43M
-46.46%
-2.03M
-54.65%
-2.27M
-52.86%
-3.00M
+1.23%
-2.66M
-27%
-4.48M
+187.69%
-4.82M
+660.36%
-2.97M
--
-3.65M
--
-1.56M
--
-634.43K
--
Depreciation Depletion & Amortization
19.79K
-8.1%
17.01K
-10.57%
15.85K
-12.52%
22.51K
+24.27%
21.53K
+18.88%
19.02K
+5.01%
18.11K
0%
18.11K
-0.01%
18.11K
+0.01%
18.11K
+200.02%
18.11K
--
18.11K
--
18.11K
--
6.04K
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
